<?xml version="1.0" encoding="UTF-8"?>
<rss version="2.0" xmlns:atom="http://www.w3.org/2005/Atom">
  <channel>
    <title>Race Oncology Ltd — News on 6ix</title>
    <link>https://6ix.com/company/race-oncology-ltd</link>
    <description>Latest news and press releases for Race Oncology Ltd on 6ix.</description>
    <language>en-us</language>
    <lastBuildDate>Wed, 22 Apr 2026 05:34:09 GMT</lastBuildDate>
    <generator>6ix RSS</generator>
    <atom:link href="https://6ix.com/rss/company/race-oncology-ltd" rel="self" type="application/rss+xml" />
    <image>
      <url>https://6ix-events-pro.s3.amazonaws.com/6ixvideo/logos/org-logo6836683278dffbe2df15ea16.webp</url>
      <title>Race Oncology Ltd</title>
      <link>https://6ix.com/company/race-oncology-ltd</link>
    </image>
    <item>
      <title>Racura presents MYC silencing data at AACR 2026</title>
      <link>https://6ix.com/company/race-oncology-ltd/news/racura-presents-myc-silencing-data-at-aacr-2026</link>
      <guid isPermaLink="true">https://6ix.com/company/race-oncology-ltd/news/racura-presents-myc-silencing-data-at-aacr-2026</guid>
      <pubDate>Wed, 22 Apr 2026 05:34:09 GMT</pubDate>
      <description>Racura presents MYC silencing data at AACR 2026</description>
    </item>
    <item>
      <title>First Patient Recruited to HARNESS-1 Lung Cancer Trial</title>
      <link>https://6ix.com/company/race-oncology-ltd/news/first-patient-recruited-to-harness-1-lung-cancer-trial</link>
      <guid isPermaLink="true">https://6ix.com/company/race-oncology-ltd/news/first-patient-recruited-to-harness-1-lung-cancer-trial</guid>
      <pubDate>Tue, 31 Mar 2026 07:14:04 GMT</pubDate>
      <description>First Patient Recruited to HARNESS-1 Lung Cancer Trial</description>
    </item>
    <item>
      <title>First Patient Dosed Safely with RC220 in Hong Kong</title>
      <link>https://6ix.com/company/race-oncology-ltd/news/first-patient-dosed-safely-with-rc220-in-hong-kong</link>
      <guid isPermaLink="true">https://6ix.com/company/race-oncology-ltd/news/first-patient-dosed-safely-with-rc220-in-hong-kong</guid>
      <pubDate>Thu, 19 Mar 2026 02:16:04 GMT</pubDate>
      <description>First Patient Dosed Safely with RC220 in Hong Kong</description>
    </item>
    <item>
      <title>Racura HARNESS-1 Trial Receives Governance Approval</title>
      <link>https://6ix.com/company/race-oncology-ltd/news/racura-harness-1-trial-receives-governance-approval</link>
      <guid isPermaLink="true">https://6ix.com/company/race-oncology-ltd/news/racura-harness-1-trial-receives-governance-approval</guid>
      <pubDate>Mon, 16 Mar 2026 02:17:06 GMT</pubDate>
      <description>Racura HARNESS-1 Trial Receives Governance Approval</description>
    </item>
    <item>
      <title>Appendix 4D &amp; Half-Year Financial Statements</title>
      <link>https://6ix.com/company/race-oncology-ltd/news/appendix-4d-and-half-year-financial-statements-3</link>
      <guid isPermaLink="true">https://6ix.com/company/race-oncology-ltd/news/appendix-4d-and-half-year-financial-statements-3</guid>
      <pubDate>Fri, 27 Feb 2026 06:52:04 GMT</pubDate>
      <description>Appendix 4D &amp; Half-Year Financial Statements</description>
    </item>
    <item>
      <title>Racura Develops Novel Cardioprotection Blood Test</title>
      <link>https://6ix.com/company/race-oncology-ltd/news/racura-develops-novel-cardioprotection-blood-test</link>
      <guid isPermaLink="true">https://6ix.com/company/race-oncology-ltd/news/racura-develops-novel-cardioprotection-blood-test</guid>
      <pubDate>Wed, 11 Feb 2026 03:30:10 GMT</pubDate>
      <description>Racura Develops Novel Cardioprotection Blood Test</description>
    </item>
    <item>
      <title>December 2025 Quarterly Activity Report and Appendix 4C</title>
      <link>https://6ix.com/company/race-oncology-ltd/news/december-2025-quarterly-activity-report-and-appendix-4c</link>
      <guid isPermaLink="true">https://6ix.com/company/race-oncology-ltd/news/december-2025-quarterly-activity-report-and-appendix-4c</guid>
      <pubDate>Thu, 29 Jan 2026 03:38:21 GMT</pubDate>
      <description>December 2025 Quarterly Activity Report and Appendix 4C</description>
    </item>
    <item>
      <title>Racura Oncology Emory University Collaboration</title>
      <link>https://6ix.com/company/race-oncology-ltd/news/racura-oncology-emory-university-collaboration</link>
      <guid isPermaLink="true">https://6ix.com/company/race-oncology-ltd/news/racura-oncology-emory-university-collaboration</guid>
      <pubDate>Wed, 14 Jan 2026 03:25:09 GMT</pubDate>
      <description>Racura Oncology Emory University Collaboration</description>
    </item>
    <item>
      <title>Racura Oncology Appoints BDD for HARNESS-1 Trial</title>
      <link>https://6ix.com/company/race-oncology-ltd/news/racura-oncology-appoints-bdd-for-harness-1-trial</link>
      <guid isPermaLink="true">https://6ix.com/company/race-oncology-ltd/news/racura-oncology-appoints-bdd-for-harness-1-trial</guid>
      <pubDate>Wed, 24 Dec 2025 03:45:10 GMT</pubDate>
      <description>Racura Oncology Appoints BDD for HARNESS-1 Trial</description>
    </item>
    <item>
      <title>Race Oncology Completes $3.22m Private Placement</title>
      <link>https://6ix.com/company/race-oncology-ltd/news/race-oncology-completes-dollar322m-private-placement</link>
      <guid isPermaLink="true">https://6ix.com/company/race-oncology-ltd/news/race-oncology-completes-dollar322m-private-placement</guid>
      <pubDate>Tue, 09 Dec 2025 03:19:12 GMT</pubDate>
      <description>Race Oncology Completes $3.22m Private Placement</description>
    </item>
    <item>
      <title>Race Receives $2.8m RD Tax Refund</title>
      <link>https://6ix.com/company/race-oncology-ltd/news/race-receives-dollar28m-rd-tax-refund</link>
      <guid isPermaLink="true">https://6ix.com/company/race-oncology-ltd/news/race-receives-dollar28m-rd-tax-refund</guid>
      <pubDate>Thu, 27 Nov 2025 03:19:13 GMT</pubDate>
      <description>Race Receives $2.8m RD Tax Refund</description>
    </item>
    <item>
      <title>HARNESS1 Lung Cancer Trial Receives Human Ethics Approval</title>
      <link>https://6ix.com/company/race-oncology-ltd/news/harness1-lung-cancer-trial-receives-human-ethics-approval</link>
      <guid isPermaLink="true">https://6ix.com/company/race-oncology-ltd/news/harness1-lung-cancer-trial-receives-human-ethics-approval</guid>
      <pubDate>Wed, 26 Nov 2025 03:49:16 GMT</pubDate>
      <description>HARNESS1 Lung Cancer Trial Receives Human Ethics Approval</description>
    </item>
    <item>
      <title>Race Clinical Program Update</title>
      <link>https://6ix.com/company/race-oncology-ltd/news/race-clinical-program-update</link>
      <guid isPermaLink="true">https://6ix.com/company/race-oncology-ltd/news/race-clinical-program-update</guid>
      <pubDate>Mon, 17 Nov 2025 03:32:08 GMT</pubDate>
      <description>Race Clinical Program Update</description>
    </item>
    <item>
      <title>September 2025 Quarterly Activity Report and Appendix 4C</title>
      <link>https://6ix.com/company/race-oncology-ltd/news/september-2025-quarterly-activity-report-and-appendix-4c</link>
      <guid isPermaLink="true">https://6ix.com/company/race-oncology-ltd/news/september-2025-quarterly-activity-report-and-appendix-4c</guid>
      <pubDate>Fri, 31 Oct 2025 02:27:13 GMT</pubDate>
      <description>September 2025 Quarterly Activity Report and Appendix 4C</description>
    </item>
    <item>
      <title>Race Presents Mechanism of Action Data at ESMO 2025</title>
      <link>https://6ix.com/company/race-oncology-ltd/news/race-presents-mechanism-of-action-data-at-esmo-2025</link>
      <guid isPermaLink="true">https://6ix.com/company/race-oncology-ltd/news/race-presents-mechanism-of-action-data-at-esmo-2025</guid>
      <pubDate>Mon, 20 Oct 2025 02:19:16 GMT</pubDate>
      <description>Race Presents Mechanism of Action Data at ESMO 2025</description>
    </item>
    <item>
      <title>Discovery of the Anticancer Mechanism of (EE)-bisantrene</title>
      <link>https://6ix.com/company/race-oncology-ltd/news/discovery-of-the-anticancer-mechanism-of-ee-bisantrene</link>
      <guid isPermaLink="true">https://6ix.com/company/race-oncology-ltd/news/discovery-of-the-anticancer-mechanism-of-ee-bisantrene</guid>
      <pubDate>Thu, 02 Oct 2025 02:45:19 GMT</pubDate>
      <description>Discovery of the Anticancer Mechanism of (EE)-bisantrene</description>
    </item>
    <item>
      <title>RC220 IND Approval from Korean MFDS</title>
      <link>https://6ix.com/company/race-oncology-ltd/news/rc220-ind-approval-from-korean-mfds</link>
      <guid isPermaLink="true">https://6ix.com/company/race-oncology-ltd/news/rc220-ind-approval-from-korean-mfds</guid>
      <pubDate>Wed, 24 Sep 2025 03:18:19 GMT</pubDate>
      <description>RC220 IND Approval from Korean MFDS</description>
    </item>
    <item>
      <title>Race Breakthrough Composition of Matter IP Discovery</title>
      <link>https://6ix.com/company/race-oncology-ltd/news/race-breakthrough-composition-of-matter-ip-discovery</link>
      <guid isPermaLink="true">https://6ix.com/company/race-oncology-ltd/news/race-breakthrough-composition-of-matter-ip-discovery</guid>
      <pubDate>Tue, 16 Sep 2025 03:20:12 GMT</pubDate>
      <description>Race Breakthrough Composition of Matter IP Discovery</description>
    </item>
    <item>
      <title>First Hong Kong Site Activated for RC220 Trial</title>
      <link>https://6ix.com/company/race-oncology-ltd/news/first-hong-kong-site-activated-for-rc220-trial</link>
      <guid isPermaLink="true">https://6ix.com/company/race-oncology-ltd/news/first-hong-kong-site-activated-for-rc220-trial</guid>
      <pubDate>Tue, 02 Sep 2025 03:42:19 GMT</pubDate>
      <description>First Hong Kong Site Activated for RC220 Trial</description>
    </item>
    <item>
      <title>Appendix 4E &amp; Annual Report</title>
      <link>https://6ix.com/company/race-oncology-ltd/news/appendix-4e-and-annual-report-32</link>
      <guid isPermaLink="true">https://6ix.com/company/race-oncology-ltd/news/appendix-4e-and-annual-report-32</guid>
      <pubDate>Tue, 26 Aug 2025 11:05:12 GMT</pubDate>
      <description>Appendix 4E &amp; Annual Report</description>
    </item>
  </channel>
</rss>